Clal Biotechnology Industries Ltd. (CBI.TA)

ILA 35.6

(-0.84%)

Annual Balance Sheets

(In ILS)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 158.38 Million 182.69 Million 444.91 Million 614.03 Million 616.96 Million 1.01 Billion
Total Current Assets 14.69 Million 16.63 Million 77.61 Million 211.09 Million 137.35 Million 139.11 Million
Cash And Short Term Investments 13.35 Million 12.88 Million 53.04 Million 186.49 Million 114.53 Million 103.77 Million
Cash and Cash Equivalents 5.72 Million 7.44 Million 53.04 Million 68.15 Million 37.55 Million 40.36 Million
Short Term Investments 7.62 Million 5.44 Million - 118.33 Million 76.97 Million 63.4 Million
Net Receivables 1.33 Million - 5.53 Million 8.89 Million 14.19 Million 2.09 Million
Inventory -7.62 Million - 3.73 Million 4.43 Million 5.57 Million 6.3 Million
Other Current Assets 7.62 Million 9.19 Million 15.29 Million 116.07 Million 3.05 Million 26.93 Million
Total Non-Current Assets 143.69 Million 166.05 Million 367.3 Million 402.93 Million 479.61 Million 876.96 Million
Net PPE 4.73 Million 5.09 Million 18.06 Million 14.94 Million 16.31 Million 7.78 Million
Good Will And Intangible Assets - - 215.77 Million 241.04 Million 304.69 Million 641.06 Million
Good Will - - - - - -
Intangible Assets - - 215.77 Million 241.04 Million 304.69 Million 641.06 Million
Long-Term Investments 130.59 Million 150.24 Million 127.83 Million 20.37 Million 70.65 Million 145.55 Million
Tax Assets - - -127.83 Million - - -
Other Non Current Assets 8.37 Million 10.71 Million 133.46 Million 126.57 Million 87.93 Million 82.56 Million
Other Assets - - - - - -
Total Liabilities 36.97 Million 37.79 Million 106.54 Million 100.24 Million 119.11 Million 148.46 Million
Total Current Liabilities 6.66 Million 2.91 Million 35.65 Million 28.27 Million 41.05 Million 23.68 Million
Account Payables - - 14.6 Million 9.62 Million 14.1 Million 10.56 Million
Tax Payables - - - - - -
Short Term Debt 5.44 Million 1.85 Million 2.43 Million 2.02 Million 12.89 Million 2.47 Million
Deferred Revenue - - - - - -2.47 Million
Other Current Liabilities 1.22 Million 1.06 Million 18.61 Million 16.63 Million 14.05 Million 13.11 Million
Total Non Current Liabilities 30.31 Million 34.88 Million 70.89 Million 71.96 Million 78.06 Million 124.78 Million
Long-Term Debt 30.31 Million 7.48 Million 9.24 Million 5.71 Million 7 Million 49.62 Million
Deferred Revenue Non Current - - 24.52 Million 5.45 Million 4.78 Million 4.34 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 27.39 Million 370 Thousand 21.87 Million 22.67 Million 37.54 Million
Other Liabilities - - - - - -
Total Equity 121.4 Million 144.89 Million 338.36 Million 513.79 Million 497.84 Million 867.61 Million
Stock Holders Equity 99.35 Million 126.02 Million 172.59 Million 306.34 Million 223.59 Million 398.89 Million
Common Stock 1.61 Million 1.61 Million 1.61 Million 1.61 Million 1.61 Million 1.61 Million
Retained Earnings -1.33 Billion -1.3 Billion -1.23 Billion -1.11 Billion -1.22 Billion -1.06 Billion
Accumulated other comprehensive income 143.75 Million 139.37 Million 125.29 Million 123.72 Million 152.04 Million 174.48 Million
Common Stock Equity 99.35 Million 126.02 Million 172.59 Million 306.34 Million 223.59 Million 398.89 Million
Capital Lease Obligation 4.82 Million 9.33 Million 11.68 Million 7.73 Million 8.96 Million -
Total Investments 138.21 Million 155.68 Million 127.83 Million 138.71 Million 147.63 Million 208.96 Million
Total Debt 35.75 Million 9.33 Million 11.68 Million 7.73 Million 19.9 Million 49.62 Million
Net Debt 30.02 Million 1.89 Million -41.36 Million -60.42 Million -17.64 Million 9.25 Million

Balance Sheet Charts